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Introduction
Vaccines are a critical component of infection prevention 
efforts worldwide and represent one of the biggest public health 
successes in history [1, 2]. Vaccines are rarely mandated, and 
therefore vaccine acceptance is an engaging area of study, 
particularly since adult vaccine coverage in the United States is 
inadequate [3]. Understanding why patients accept or decline 
recommended vaccines is important in order to develop 
evidence-based, tailored messages and interventions to increase 
vaccine uptake [4, 5]. In healthy individuals, such as those 
requiring vaccines for international travel, little description of 
vaccine acceptance has been documented [6]. In this setting, 
specialized computer software is available where vaccines 
are suggested for travelers to various areas of the world based 
on likelihood of exposure. Since these vaccines are rarely a 
prerequisite for travel to any particular location, their final 
delivery is left to the discretion of the individual. The purpose of 
this study was to evaluate reasons for vaccine declination in an 
international vaccine and travel clinic where vaccines are paid 
for out-of-pocket. 
Methods
This was a secondary analysis of a cross-sectional study focused 
on predictors of the intention to be vaccinated (4). Briefly, the 
initial study was conducted from November 2013 through July 
2014 and included all unique, consecutive, individuals seeking 
care at the University of Louisville Vaccine and International 
Travel clinic for pre-travel consultation. Persons requiring only 
boosters were excluded from the analysis. After evaluation by 
a healthcare provider, individuals are offered vaccines based 
on their personal medical history and/or intended travel 
epidemiology. Because of this, individuals were evaluated for 
vaccines that may be suggested for general medical reasons 
as opposed to solely travel-related reasons. Vaccines offered 
included: Hepatitis A and B, Influenza (injectable, nasal mist, or 
intradermal), Japanese encephalitis, measles/mumps/rubella 
(MMR), meningococcal, polio, pneumococcal, rabies, tetanus/
diphtheria/pertussis (Tdap), tetanus/diphtheria (Td), typhoid 
(injectable or oral), varicella, and zoster. The University of 
Louisville Human Subjects Protection Program Office approved 
this study prior to any data collection (IRB # 12.0470). Consent 
was obtained upon beginning the survey on a tablet computer.
Vaccines suggested based on patient history (e.g. pneumococcal, 
influenza) or travel future were documented in a REDCap 
database [7]. With the exception of yellow fever vaccine for 
some countries, few vaccines are routinely required for travel 
and in our clinic,  individuals were given the option to accept or 
decline each suggested vaccine. Other notable exceptions where 
vaccines may be required for travel include meningococcal 
vaccine for travel to the Hajj, but this requirement was outside of 
the time frame of the current study. In the event of a declination, 
the reasons were documented in the same database. Frequencies 
and percentages for each reason were calculated and tabulated. 
R v3.3.2 was used for all analysis [8].
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Results 
A total of 249 unique individuals were included in the analysis. 
The most common vaccine offered was injectable typhoid in 
210 (84%) of patients. The least frequent vaccine offered was 
shingles in 4 (1.6%) individuals. The top three most frequently 
declined vaccines were: Pneumococcal Conjugate Vaccine 
(PCV-13) with 7/7 (100%) of patients declining, Rabies with 
113/123 (91.9%) of individuals declining, and Varicella with 
19/22 (86.4%) of individuals declining vaccination. A table of 
each vaccine, the total offered, declined, and the frequency and 
percentage of reasons for individuals declining offered vaccines 
can be found in Figure 1. Declination due to perceived risks of 
the vaccine was the most often reported reason for not receiving 
any particular offered vaccine, with an average of over one third 
of individuals indicating this as the major reason for declination. 
Yellow fever vaccine was the most accepted vaccine, with 6/78 
(7.7%) of individuals declining the vaccine. Four individuals 
who would have been offered the yellow fever vaccine were 
deemed ineligible due to contraindications and were removed 
from the denominator.
Discussion
This study reports the reasons for declining suggested vaccines 
in otherwise healthy, low-risk individuals seeking care at a large 
Vaccine and International Travel Center. Although this clinic 
is a cash-only clinic which requires individuals to pay out-of-
pocket, declination due to cost or intention to receive the vaccine 
elsewhere due to insurance were not major factors in individual 
declination decisions. Declination due to perceived risks of the 
vaccines were by far the most common rationale suggesting 
continued need for public health educational campaigns 
regarding the importance of vaccination. This differs from a 
report from the Global TravEpiNet study, which identified lack 
of perceived risk of the disease as the main factor for declination 
[6]. Yellow fever was the most accepted vaccine as expected, 
since this vaccine is the only one required for travel to certain 
areas. 
This study has several limitations. First the sample size was 
relatively small and was obtained from a single center.  These 
factors limit the generalizability of our findings. Further, 
we did not collect data on the reason for travel and if friends 
or family were the rationale for travel. These factors were 
previously documented to modify the rate and rationale for 
vaccine acceptance [6]. Another limitation is with respect to 
required vaccines. Occasionally some countries have required 
evidence of various vaccines (e.g. MMR during an outbreak). 
Since these requirements change rapidly, some individuals 
may have biased some results. With respect to all vaccines, we 
didn’t collect data on if individuals followed through with travel. 
This is particularly important for Yellow Fever vaccine, since it 
is required for travel to their destination. We were not able to 
document if the individual did not travel because of the lack of 
obtaining the vaccine, or if they received it elsewhere, bypassing 
their rationale for declination in our clinic.
In conclusion, we documented a low rate of vaccine acceptance 
in our international travelers, which varied based on the 
vaccine. Since immunizations are a critical component of public 
health infection prevention activities, there is a substantial need 
for active education and policy to assist in the prevention of 
preventable infection.
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Figure 1 Reasons for vaccine declination (frequency and percentage) in healthy individuals attending an international travel and vaccine center, 
by vaccine offered. 
Reasons for Declining or Not Obtaining Offered Vaccine 






























































































































































































































































































































































Hepatitis A 159 95, (59.7) 8, (8.4) 9, (9.5) 14, (14.7) 6, (6.3) 1, (1.1) 1, (1.1) 12, (12.6) 43, (45.3) 1, (1.1)
Hepatitis B 117 101, (86.3) 4, (4) 5, (5) 13, (12.9) 10, (9.9) 0, (0) 1, (1) 22, (21.8) 45, (44.6) 1, (1)
Hepatitis A/B Dual 99 55, (55.6) 4, (7.3) 3, (5.5) 2, (3.6) 6, (10.9) 0, (0) 1, (1.8) 22, (40) 15, (27.3) 2, (3.6)
Influenza 112 89, (79.5) 2, (2.2) 4, (4.5) 3, (3.4) 34, (38.2) 0, (0) 5, (5.6) 41, (46.1) 0, (0) 0, (0)
Japanese Encephalitis 57 41, (71.9) 13, (31.7) 2, (4.9) 0, (0) 0, (0) 0, (0) 1, (2.4) 25, (61) 0, (0)
Measles, Mumps, Rubella (MMR) 24 19, (79.2) 0, (0) 1, (5.3) 5, (26.3) 10, (52.6) 0, (0) 0, (0) 2, (10.5) 1, (5.3)
Meningitis (Menactra) 37 24, (64.9) 9, (37.5) 5, (20.8) 0, (0) 2, (8.3) 0, (0) 0, (0) 8, (33.3) 0, (0)
Meningitis (Menomune) 17 11, (64.7) 2, (18.2) 2, (18.2) 0, (0) 0, (0) 0, (0) 0, (0) 7, (63.6) 0, (0)
Polio 30 14, (46.7) 1, (7.1) 2, (14.3) 4, (28.6) 4, (28.6) 0, (0) 0, (0) 3, (21.4) 0, (0)
Pneumococcal Conjugate (PCV-13) 7 7, (100) 0, (0) 1, (14.3) 1, (14.3) 1, (14.3) 0, (0) 0, (0) 4, (57.1) 0, (0)
Rabies 123 113, (91.9) 19, (16.8) 1, (0.9) 1, (0.9) 0, (0) 0, (0) 1, (0.9) 90, (79.6) 1, (0.9)
Tetanus, Diphtheria, Acellular Pertussis 111 35, (31.5) 4, (11.4) 7, (20) 9, (25.7) 4, (11.4) 1, (2.9) 2, (5.7) 8, (22.9) 0, (0)
Injectable Typhoid 218 116, (53.2) 6, (5.2) 2, (1.7) 0, (0) 0, (0) 17, (14.7) 1, (0.9) 16, (13.8) 21, (18.1) 52, (44.8) 1, (0.9)
Oral Typhoid 210 122, (58.1) 5, (4.1) 2, (1.6) 0, (0) 0, (0) 0, (0) 21, (17.2) 21, (17.2) 72, (59) 1, (0.8)
Varicella 22 19, (86.4) 0, (0) 0, (0) 0, (0) 9, (47.4) 0, (0) 1, (5.3) 6, (31.6) 3, (15.8)
Yellow Fever 78 6, (7.7) 0, (0) 0, (0) 0, (0) 0, (0) 0, (0) 4, (66.6) 2, (33.3) 0 (0.0)
Shingles 4 2, (50) 0, (0) 2, (100) 0, (0) 0, (0) 0, (0) 0, (0) 0, (0) 0, (0)
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